Risk factors for neuroleptic malignant syndrome. A case-control study.
about
Neuroleptic malignant syndrome.Antipsychotic dose escalation as a trigger for neuroleptic malignant syndrome (NMS): literature review and case series reportExcited Delirium and Sudden Death: A Syndromal Disorder at the Extreme End of the Neuropsychiatric ContinuumThe fallacy of the medical model and the dangers of psychotropic drugs as a mode of treatment for mental disorders.Neuroleptic malignant syndrome in a child treated with an atypical antipsychotic.A case of recurrent neuroleptic malignant syndrome.A case of neuroleptic malignant syndrome induced by perospirone.Neuroleptic malignant syndrome: a preventive program.Low serum iron as a possible risk factor for neuroleptic malignant syndrome.Risk factors in neuroleptic malignant syndrome.Delirious mania.Increased risk of occurrence of neuroleptic malignant syndrome on combined treatment with lithium and neurolepticNeuroleptic malignant syndrome: a review for neurohospitalistsOlanzapine induced neuroleptic malignant syndrome--a case review.A randomized, double-blind, placebo-controlled study of rapid-acting intramuscular olanzapine in Japanese patients for schizophrenia with acute agitation.The parkinsonism-hyperpyrexia syndrome.Clinical and pharmacologic risk factors for neuroleptic malignant syndrome and their association with death.World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance.Ziprasidone in the treatment of mania in bipolar disorder.Movement disorder emergencies.Sudden discontinuation and reinstitution of olanzapine-associated atypical neuroleptic malignant syndrome in a patient undergoing lung surgery.The catatonic dilemma expandedPsychiatryNeuroleptic malignant syndrome in elderly patients.Neuroleptic Malignant Syndrome Associated with Refractory Acute Disseminated Encephalomyelitis.Olanzapine-Induced Malignant Neuroleptic SyndromeAscertaining instances of neuroleptic malignant syndrome in a secondary mental healthcare electronic medical records database: the SLAM BRC Case RegisterA naturalistic comparison of the efficacy and safety of intramuscular olanzapine and intramuscular levomepromazine in agitated elderly patients with schizophreniaA naturalistic comparison of the efficacy and safety of intramuscular olanzapine and intramuscular haloperidol in agitated elderly patients with schizophrenia.Neuroleptic malignant syndrome--follow-up study.Neuroleptic malignant syndrome: an easily overlooked neurologic emergency.Neuroleptic malignant syndrome and its controversies.Neuroleptic malignant syndrome: a neuroimmunologic hypothesis.Retrospective chart review on exposure to psychotropic medications associated with neuroleptic malignant syndrome.A systematic review of sex and age factors in neuroleptic malignant syndrome diagnosis frequency.Delirium followed by neuroleptic malignant syndrome in rehabilitation setting. Is it anger reaction before discharge?Atypical neuroleptic malignant syndrome.Case reports of neuroleptic malignant syndrome in context of quetiapine use.Atypical neuroleptic malignant syndrome: diagnostic controversies and considerations.Olanzapine-induced neuroleptic malignant syndrome in a patient with bipolar affective disorder: Does quetiapine holds the solution?
P2860
Q24521308-DEDF0BE7-7B2E-41E9-83F2-6380ABA4BD67Q27012733-697DD30F-AA28-4AE7-9A32-F5D11B9086AFQ28076564-C7A5E374-51BF-4754-9C3C-8C1499407922Q30355790-B2CD2891-5990-4F40-AAD3-8EB19AEE6C7DQ33208807-5C334579-75CF-4094-9BF0-D3F043A615B9Q33744490-0B8BF3A1-0129-43E6-B0C5-8E1492F837B3Q33744583-0AAFB497-9C5E-41BA-A070-9711592C3F1BQ33921019-3E4A0FB6-38CC-4DD1-A572-B9FFC3631B14Q34064639-C95C74E5-9228-42F0-A375-569611272F9EQ34183279-F107EA9D-8187-43BB-B142-CC4428F1EA12Q34188595-A0A1FAB2-D7B2-42D5-97E9-2AFFE7F60DBAQ34256343-73E3548F-D5F1-4AB5-8C13-7E114CD6C877Q34367132-F8CFFDD0-ADED-4578-B3A4-9C50FD9CDD1CQ34533979-CAEE1E95-228C-45B8-AECB-4C845FF301B5Q34546038-ACA9E865-917A-4433-818C-4D5EFC948797Q34595740-FA4DC100-3E39-4AB8-B714-21AF194BBCACQ34619015-0FB79A00-2D61-4149-BBF3-E4008D2AA2F9Q34640811-CB08E8B7-3EA9-4A59-9B55-06EF28616C72Q34966022-23042D91-9E98-49A7-A581-82A3C3DFFAABQ35975824-BD1D0F8D-95C2-4207-8B00-0E48202F7BC3Q36046911-DA28516B-17AF-4D93-AD23-EDCFC7DE0D94Q36588430-475B4C53-BDBD-42FA-9DC3-DB0E73A87F8AQ36718237-AC4799CC-3DA6-4C86-AB8B-C00FFAE00CCEQ36787356-EE7C5FB5-ED0D-47CB-8A06-CC7A8D3D5595Q36938390-B0196980-CDB4-482B-BD9D-8FE5A08B0DDAQ36972060-F3F6B1FC-CC2D-4B54-993D-9C98063F4BFCQ37079017-1A561A14-E1CE-4724-9107-35D7E54AEBCEQ37164506-5258CDFA-9F9A-4851-A474-6D4BA2870408Q37343588-B85F9440-B3E3-45EC-A90F-7002B0DDC532Q37378767-0B42FE25-8A42-4C01-80A6-0566905D0A9FQ37596135-5D57FB0F-EED4-4DBD-918C-AE93872E14FEQ37715871-FDD65775-26E9-4CF0-87AA-20A1D154463BQ37778936-6FEE850A-3022-4FC3-91E2-C8AEAE55D5FEQ38163049-E99BADB7-8DE1-4E88-8602-1A4810AEBD60Q39113019-39A4F320-511F-4625-A556-F74BDD87321AQ39222320-9392DBCD-B893-4D4E-8D35-BAF3E50D7E3DQ40101519-1893A5C7-846F-48C6-B038-07A0CECC2104Q40247317-574C32C2-EBC5-426C-BDFC-80E477900DCAQ40423742-FE49617A-F7D1-4384-B8AC-1D3ACCF0D22AQ41763536-3803A691-AB6D-47F1-8ABB-02A0DBA482D3
P2860
Risk factors for neuroleptic malignant syndrome. A case-control study.
description
1989 nî lūn-bûn
@nan
1989 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Risk factors for neuroleptic malignant syndrome. A case-control study.
@ast
Risk factors for neuroleptic malignant syndrome. A case-control study.
@en
Risk factors for neuroleptic malignant syndrome. A case-control study.
@nl
type
label
Risk factors for neuroleptic malignant syndrome. A case-control study.
@ast
Risk factors for neuroleptic malignant syndrome. A case-control study.
@en
Risk factors for neuroleptic malignant syndrome. A case-control study.
@nl
prefLabel
Risk factors for neuroleptic malignant syndrome. A case-control study.
@ast
Risk factors for neuroleptic malignant syndrome. A case-control study.
@en
Risk factors for neuroleptic malignant syndrome. A case-control study.
@nl
P2093
P1433
P1476
Risk factors for neuroleptic malignant syndrome. A case-control study.
@en
P2093
Keck PE Jr
McElroy SL
Nierenberg AA
Pope HG Jr
P304
P356
10.1001/ARCHPSYC.1989.01810100056011
P407
P577
1989-10-01T00:00:00Z